http://orcid.org/0000-0002-1408-4968
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Andrzej Pilc, Agata Machaczka, Paweł Kawalec, Jodi L. Smith & Jeffrey M. Witkin. (2022) Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism. Expert Opinion on Drug Discovery 17:10, pages 1131-1146.
Read now
Read now
Bartłomiej Pochwat, Gabriel Nowak & Bernadeta Szewczyk. (2019) An update on NMDA antagonists in depression. Expert Review of Neurotherapeutics 19:11, pages 1055-1067.
Read now
Read now
D.S. Karlov, O.I. Barygin, M.Y. Dron, V.A. Palyulin, V.V. Grigoriev & M.V. Fedorov. (2019) Short peptide with an inhibitory activity on the NMDA/Gly-induced currents. SAR and QSAR in Environmental Research 30:9, pages 683-695.
Read now
Read now
Articles from other publishers (16)
Courtney M. Vecera, Alan C. Courtes, Gregory Jones, Jair C. Soares & Rodrigo Machado-Vieira. (2023) Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression. Pharmaceuticals 16:11, pages 1572.
Crossref
Crossref
Yuanyuan Zhu, Rui Wang, Ze Fan, Danlei Luo, Guohong Cai, Xinyang Li, Jiao Han, Lixia Zhuo, Li Zhang, Haifeng Zhang, Yan Li & Shengxi Wu. (2022) Taurine Alleviates Chronic Social Defeat Stress-Induced Depression by Protecting Cortical Neurons from Dendritic Spine Loss. Cellular and Molecular Neurobiology 43:2, pages 827-840.
Crossref
Crossref
Daniel Felipe Ariza-Salamanca, María Gabriela Corrales-Hernández, María José Pachón-Londoño & Isabella Hernández-Duarte. (2022) Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Patricio Molero, Enrique Aubá, María del Mar Unceta & Felipe Ortuño Sánchez-Pedreño. 2022. Glutamate and Neuropsychiatric Disorders. Glutamate and Neuropsychiatric Disorders
337
357
.
Hyewon Kim, Yong-Ku Kim & Hong Jin Jeon. 2022. Translational Research Methods for Major Depressive Disorder. Translational Research Methods for Major Depressive Disorder
327
334
.
Clarissa Yates, Jennifer L. Kruse, J. Blair Price, Avril A. B. Robertson & Susannah J. Tye. (2021) Modulating Neuroplasticity: Lessons Learned from Antidepressants and Emerging Novel Therapeutics. Current Treatment Options in Psychiatry 8:4, pages 229-257.
Crossref
Crossref
Ya-Ting Wang, Xiao-Le Wang, Si-Tong Feng, Nai-Hong Chen, Zhen-Zhen Wang & Yi Zhang. (2021) Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression. Pharmacological Research 171, pages 105761.
Crossref
Crossref
Marsal Sanches, Joao Quevedo & Jair C. Soares. (2021) New agents and perspectives in the pharmacological treatment of major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, pages 110157.
Crossref
Crossref
Ross J. Baldessarini, Gustavo H. Vázquez & Leonardo Tondo. (2020) Bipolar depression: a major unsolved challenge. International Journal of Bipolar Disorders 8:1.
Crossref
Crossref
Athira K V, Arathy S Mohan & Sumana Chakravarty. (2020) Rapid acting antidepressants in the mTOR pathway: Current evidence. Brain Research Bulletin 163, pages 170-177.
Crossref
Crossref
William V. BoboPatricio Riva-PosseFernando S. GoesSagar V. Parikh. (2020) Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine. FOCUS 18:2, pages 181-192.
Crossref
Crossref
Luis Jimenez-Trevino, Leticia Gonzalez-Blanco, Clara Alvarez-Vazquez, Julia Rodriguez-Revuelta & Pilar A. Saiz Martinez. 2020. Behavioral Neurobiology of Suicide and Self Harm. Behavioral Neurobiology of Suicide and Self Harm
179
196
.
Ju-Chun Pei, Wei-Li Hung, Bei-Xuan Lin, Min-Han Shih, Liang-Yin Lu, Da-Zhong Luo, Hwan-Ching Tai, Vincent Studer, Ming-Yuan Min & Wen-Sung Lai. (2019) Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia. Journal of Psychopharmacology 33:10, pages 1288-1302.
Crossref
Crossref
Vitor Silva Pereira, Sâmia R.L. Joca, Brian H. Harvey, Betina Elfving & Gregers Wegener. (2019) Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression. Acta Neuropsychiatrica 31:05, pages 258-265.
Crossref
Crossref
Macarena Lorena Herrera, Osvaldo Martín Basmadjian, Eugenia Falomir Lockhart, Franco Juan-Cruz Dolcetti, Claudia Beatriz Hereñú & María José Bellini. (2019) Novel adenoviral IGF-1 administration modulates the association between depressive symptoms and aging: Does gender matter?. Behavioural Brain Research 372, pages 112050.
Crossref
Crossref
Marek Krzystanek & Artur Pałasz. (2019) NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality. International Journal of Molecular Sciences 20:6, pages 1442.
Crossref
Crossref